Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 02.03. FARMACOS ANTIHIPERTENSIVOS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
This medicine has the best evidence for effectiveness and safety. |
| Guyana. Essential Medicines List. 2020-2021 | Reserved for specialist use | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 24:08 Anti-hypertensive agents | No observations |
| Belize. National Drug Formulary | 12.03 Antihypertensive medicines | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines | No observations |
| WHO Model List of Essential Medicines (2021) | 12.4. Medicines used in heart failure |
This medicine has the best evidence for effectiveness and safety. |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 24:08 Anti-hypertensive agents | No observations |
| Haiti. National List of Essential Medicines | 12.03 Anti-hypertensives | No observations |
| Haiti. National List of Essential Medicines | 12.04 Medicines for heart failure | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.32.08 Angiotensin II Receptor Antagonist | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.05.04.02 Angiotensin II Receptor Antagonists | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 12.3 Anti-Hypertensives | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Cvs Angiotensin II Antagonists | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | C. APARELHO CARDIOVASCULAR | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 11.03. ANTIHIPERTENSIVOS | No observations |
| List | Section | Observation |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.06 ANGIOTENSIN II RECEPTOR ANTAGONIST | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 09. AGENTES QUE ACTÚAN SOBRE EL SISTEMA RENINA-ANGIOTENSINA | No observations |
| WHO Model List of Essential Medicines (2021) | 12.4. Medicines used in heart failure |
This medicine has the best evidence for effectiveness and safety. |
| Suriname. NGK-C-011 | 12.3 Antihypertensives | No observations |
| Suriname. NGK-C-011 | 12.4 Medicines for Heart Failure | No observations |
| Suriname. NGK-C-011 | 29.2 Other Special Essential Medicines | No observations |
| Haiti. National List of Essential Medicines | 12.03 Anti-hypertensives | No observations |
| Haiti. National List of Essential Medicines | 12.04 Medicines for heart failure | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.32.08 Angiotensin II Receptor Antagonist | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.05.04.02 Angiotensin II Receptor Antagonists | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
This medicine has the best evidence for effectiveness and safety. |
| WHO Model List of Essential Medicines (2021) | 12.4. Medicines used in heart failure |
This medicine has the best evidence for effectiveness and safety. |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.06 ANGIOTENSIN II RECEPTOR ANTAGONIST | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Reserved for specialist use | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 24:08 Anti-hypertensive agents | No observations |
| Haiti. National List of Essential Medicines | 12.03 Anti-hypertensives | No observations |
| Haiti. National List of Essential Medicines | 12.04 Medicines for heart failure | No observations |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | No observations |
| Belize. National Drug Formulary | 12.03 Antihypertensive medicines | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.05.04.02 Angiotensin II Receptor Antagonists | No observations |